Osteoporosis after blood and marrow transplantation: Clinical aspects

Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older

1997 • 2,320 citations

Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women

1997 • 1,641 citations

Pre-Existing Fractures and Bone Mass Predict Vertebral Fracture Incidence in Women

1991 • 1,113 citations

Solid Cancers after Bone Marrow Transplantation

1997 • 950 citations

Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's Disease

1996 • 904 citations

Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen

1992 • 824 citations

Esophagitis Associated with the Use of Alendronate

1996 • 763 citations

Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women

1994 • 692 citations

Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families

1999 • 479 citations

Excessive Dietary Intake of Vitamin A Is Associated with Reduced Bone Mineral Density and Increased Risk for Hip Fracture

1998 • 398 citations

How Hip and Whole-Body Bone Mineral Density Predict Hip Fracture in Elderly Women: The EPIDOS Prospective Study

1998 • 345 citations

Hip Fracture Prediction in Elderly Men and Women: Validation in the Rotterdam Study

1998 • 330 citations

Ovarian function following marrow transplantation for aplastic anemia or leukemia.

1988 • 325 citations

Inhibition of Luteinizing Hormone Secretion Induced by Synthetic LRH by Long-term Treatment with Glucocorticoids in Human Subjects

1975 • 262 citations

Clinical outcomes and treatment of hip fractures

1997 • 250 citations

Treatment of Established Postmenopausal Osteoporosis with Raloxifene: A Randomized Trial

1998 • 243 citations

Determinants of Peak Bone Mass: Clinical and Genetic Analyses in a Young Female Canadian Cohort

1999 • 220 citations

Long‐term safety of treatment with recombinant human granulocyte colony‐stimulating factor (r‐metHuG‐CSF) in patients with severe congenital neutropenias

1994 • 211 citations

Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption

1992 • 201 citations

The Role of Hormone Replacement Therapy in the Risk for Breast Cancer and Total Mortality in Women with a Family History of Breast Cancer

1997 • 189 citations

Fluoride Salts are no Better at Preventing New Vertebral Fractures than Calcium-Vitamin D in Postmenopausal Osteoporosis: The FAVOStudy

1998 • 172 citations

Smoking, smoking cessation, and risk of hip fracture in women

1999 • 157 citations

Estrogens in the prevention of osteoporosis in postmenopausal women

1989 • 156 citations

Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women

1995 • 146 citations

Long-term Hormone Replacement Therapy and Risk of Breast Cancer in Postmenopausal Women

1995 • 144 citations

A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin

1999 • 115 citations

Osteoporosis and Decline of Gonadal Function in the Elderly Male

1984 • 102 citations

Bone Mass in Middle-Aged Osteoporotic Men and Their Relatives: Familial Effect

1998 • 102 citations

Patterns of gonadal dysfunction following bone marrow transplantation

1998 • 89 citations

Ovarian function after autologous bone marrow transplantation.

1998 • 86 citations

Correlation of Serum Osteocalcin Fractions with Bone Mineral Density in Women During the First 10 Years after Menopause

1998 • 84 citations

Fluoride Treatment Increased Serum IGF-1, Bone Turnover, and Bone Mass, but Not Bone Strength, in Rabbits

1997 • 80 citations

Growth and endocrine function after bone marrow transplantation

1995 • 76 citations

Bone density loss during treatment of chronic GVHD.

1996 • 74 citations

Reduced bone mineral density in men following chemotherapy for Hodgkin's disease

1994 • 74 citations

The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation

1996 • 69 citations

Reduction of Bone Mass in Women after Bone Marrow Transplantation

1997 • 64 citations

Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism

1994 • 60 citations

The Effect of Fluoride Treatment on Bone Mineral in Rabbits

1999 • 57 citations

Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disorders

1989 • 43 citations

Bone densitometry in patients with multiple myeloma

1992 • 41 citations

Salmon calcitonin in the prevention of bone loss at perimenopause

1996 • 40 citations

Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.

1996 • 34 citations

Monitoring of Bone Metabolism after Bone Marrow Transplantation by Measuring Two Different Markers of Bone Turnover

1996 • 32 citations

36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.

1999 • 24 citations

Estimation of Bone Mineral Density and Bone Loss by Means of Bone Metabolic Markers in Postmenopausal Women.

1995 • 16 citations

Effect of calcitonin treatment on osteoclast counts in Paget's disease of bone.

1978 • 12 citations

Osteoclast-Mediated Bone Resorption Is Stimulated During Short-Term Administration of Granulocyte Colony-Stimulating Factor But Is Not Responsible for Hematopoietic Progenitor Cell Mobilization

1998 • 8 citations

Hypomagnesemia and Renal Magnesium Wasting in Renal Transplant Recipients Receiving Cyclosporine

1988 • 6 citations